Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis

20Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The protein encoded by bcl-2 proto-oncogene plays an important role in the mitochondria-mediated apoptotic pathway. Although the general role of Bcl-2 is anti-apoptotic, previous work showed that Bcl-2 fragments cleaved by caspases could promote apoptotic process. We report herein that Bcl-2 protein was cleaved to produce two fragments of around 23 kDa in human hepatocarcinoma BEL-7404 cells or in Bcl-2 overexpressing CHO cells induced by cisplatin. Treating cells with the general caspase inhibitor z-VAD-fmk blocked the induced cleavage of Bcl-2. Mutagenesis analyses showed that Bcl-2 was cleaved by caspases at two adjacent recognition sites in the loop domain (YEWD31AGD 34V), which could be inhibited by caspase-8 and -3 inhibitors, respectively. Overexpression of the carboxyl terminal 23 kDa fragments increased the sensitivity of CHO cells to cisplatin-induced apoptosis. These results indicate that Bcl-2 can be cleaved into two close fragments by different caspases during cisplatin-induced apoptosis, both of which contribute to the acceleration of apoptotic process. © 2007 IBCB, SIBS, CAS All rights reserved.

Cite

CITATION STYLE

APA

Zhu, J., Yang, Y., & Wu, J. (2007). Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis. Cell Research, 17(5), 441–448. https://doi.org/10.1038/cr.2007.36

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free